Latest News

Stroke risk rises for women with history of infertility, miscarriage, stillbirth


 

FROM THE BMJ

Data support gender-specific stroke risk stratification

“Studies that seek to understand gender differences and disparities in adverse outcomes, such as stroke risk, are extremely important given that women historically were excluded from research studies,” Catherine M. Albright, MD, of the University of Washington, Seattle, said in an interview. “By doing these studies, we are able to better risk stratify people in order to better predict and modify risks,” added Dr. Albright, who was not involved in the current study.

“It is well known than adverse pregnancy outcomes such as hypertension in pregnancy, fetal growth restriction, and preterm birth, lead to increased risk of cardiovascular disease and stroke later in life, so the general findings of an association between other adverse reproductive and pregnancy outcomes leads to increased stroke risk are not surprising,” she said.

“The take-home message is that outcomes for pregnancy really do provide a window to future health,” said Dr. Albright. “For clinicians, especially non-ob.gyns., knowing a complete pregnancy history for any new patient is important and can help risk-stratify patients, especially as we continue to gain knowledge like what is shown in this study.”

However, “this study did not evaluate why individual patients may have had infertility, recurrent pregnancy loss, or stillbirth, so research to look further into this association to determine if there is an underlying medical condition that could be treated and therefore possibly reduce both pregnancy complications and future stroke risks would be important,” Dr. Albright noted.

The study was supported by the Australian National Health and Medical Research Council Centres of Research Excellence; one corresponding author was supported by an Australian National Health and Medical Research Council Investigator grant. The researchers had no financial conflicts to disclose. Dr. Albright had no financial conflicts to disclose.

Pages

Recommended Reading

Even light drinking ups CV risk; harm rises along with intake
MDedge Endocrinology
SCORED: Sotagliflozin shows robust MACE benefit
MDedge Endocrinology
Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival
MDedge Endocrinology
Bariatric surgery cuts cardiovascular events, even in seniors
MDedge Endocrinology
Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI
MDedge Endocrinology
Traumatic brain injury linked to ‘striking’ risk for CVD, diabetes, brain disorders
MDedge Endocrinology
Espresso coffee linked to increased total cholesterol
MDedge Endocrinology
Exenatide linked to less hyperglycemia after stroke
MDedge Endocrinology
Updated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhage
MDedge Endocrinology
Jury still out on cardiovascular safety of testosterone
MDedge Endocrinology